News

Lilly’s Zepbound faces a potential weight-loss rival. It’s made by a Chinese biotech
A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...
Obesity Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working In The Therapeutics Segment Delveinsight
DelveInsight's“ Obesity Pipeline Insigh t 2025 ” report provides comprehensive insights about 80+ companies and 100+ pipeline ...